Cargando…

Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with high mortality worldwide. Accumulating researches have indicated that long non‑coding RNAs (lncRNAs) are involved in varies human cancers, including HCC. Nevertheless, the specific molecular mechanism of lncRN...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, ZhenYu, Ye, ZhenYu, Xie, JiaMing, Chen, Wei, Li, Wei, Xing, ChunGen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645132/
https://www.ncbi.nlm.nih.gov/pubmed/34863279
http://dx.doi.org/10.1186/s13062-021-00312-8
_version_ 1784610245999329280
author Feng, ZhenYu
Ye, ZhenYu
Xie, JiaMing
Chen, Wei
Li, Wei
Xing, ChunGen
author_facet Feng, ZhenYu
Ye, ZhenYu
Xie, JiaMing
Chen, Wei
Li, Wei
Xing, ChunGen
author_sort Feng, ZhenYu
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with high mortality worldwide. Accumulating researches have indicated that long non‑coding RNAs (lncRNAs) are involved in varies human cancers, including HCC. Nevertheless, the specific molecular mechanism of lncRNA lysyl oxidase like 1 antisense RNA 1 (LOXL1-AS1) in HCC is still unclear. METHODS: LOXL1-AS1 expression was tested via qRT-PCR in HCC cells. Functional and mechanism assays were respectively done to evaluate the biological functions of HCC cells and the potential interaction of LOXL1-AS1 and other factors. RESULTS: We discovered that LOXL1-AS1 was high expressed in HCC cells. Inhibition of LOXL1-AS1 repressed cell proliferation, migration and invasion, but enhanced cell apoptosis in HCC. Further, miR-3614-5p was proven to be sponged by LOXL1-AS1. Additionally, Yin Yang 1 (YY1) was proven as the target gene of miR-3614-5p, and YY1 depletion could repress HCC cell malignant behaviors. YY1 could also transcriptionally activate LOXL1-AS1 expression. In rescue assays, we confirmed that overexpression of YY1 or miR-3614-5p inhibition could reverse the suppressive effects of LOXL1-AS1 silence on the malignant behaviors of HCC cells. CONCLUSION: In short, LOXL1-AS1/miR-3614-5p/YY1 forms a positive loop in modulating HCC cell malignant behaviors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13062-021-00312-8.
format Online
Article
Text
id pubmed-8645132
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86451322021-12-06 Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma Feng, ZhenYu Ye, ZhenYu Xie, JiaMing Chen, Wei Li, Wei Xing, ChunGen Biol Direct Research BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with high mortality worldwide. Accumulating researches have indicated that long non‑coding RNAs (lncRNAs) are involved in varies human cancers, including HCC. Nevertheless, the specific molecular mechanism of lncRNA lysyl oxidase like 1 antisense RNA 1 (LOXL1-AS1) in HCC is still unclear. METHODS: LOXL1-AS1 expression was tested via qRT-PCR in HCC cells. Functional and mechanism assays were respectively done to evaluate the biological functions of HCC cells and the potential interaction of LOXL1-AS1 and other factors. RESULTS: We discovered that LOXL1-AS1 was high expressed in HCC cells. Inhibition of LOXL1-AS1 repressed cell proliferation, migration and invasion, but enhanced cell apoptosis in HCC. Further, miR-3614-5p was proven to be sponged by LOXL1-AS1. Additionally, Yin Yang 1 (YY1) was proven as the target gene of miR-3614-5p, and YY1 depletion could repress HCC cell malignant behaviors. YY1 could also transcriptionally activate LOXL1-AS1 expression. In rescue assays, we confirmed that overexpression of YY1 or miR-3614-5p inhibition could reverse the suppressive effects of LOXL1-AS1 silence on the malignant behaviors of HCC cells. CONCLUSION: In short, LOXL1-AS1/miR-3614-5p/YY1 forms a positive loop in modulating HCC cell malignant behaviors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13062-021-00312-8. BioMed Central 2021-12-04 /pmc/articles/PMC8645132/ /pubmed/34863279 http://dx.doi.org/10.1186/s13062-021-00312-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Feng, ZhenYu
Ye, ZhenYu
Xie, JiaMing
Chen, Wei
Li, Wei
Xing, ChunGen
Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
title Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
title_full Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
title_fullStr Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
title_full_unstemmed Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
title_short Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
title_sort study on the mechanism of loxl1-as1/mir-3614-5p/yy1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645132/
https://www.ncbi.nlm.nih.gov/pubmed/34863279
http://dx.doi.org/10.1186/s13062-021-00312-8
work_keys_str_mv AT fengzhenyu studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma
AT yezhenyu studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma
AT xiejiaming studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma
AT chenwei studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma
AT liwei studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma
AT xingchungen studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma